Polen Capital made significant adjustments to its Global Growth Portfolio in the fourth quarter of 2025 by initiating new positions in Tencent Holdings and Spotify, while...
UPDATE: The U.S. Food and Drug Administration (FDA) has just approved Novo Nordisk’s groundbreaking weight-loss pill, Wegovy, marking a significant milestone in the fight against obesity....
The European Medicines Agency’s committee has recommended the extension of Eli Lilly’s diabetes medication, Mounjaro, for use in children and adolescents aged 10 years and older....
China has officially included drugs from major pharmaceutical companies Eli Lilly, Pfizer, and Johnson & Johnson on its inaugural innovative drug catalog for private insurance. This...
Pharmaceutical giants Eli Lilly, Pfizer, and Johnson & Johnson have been included in China’s inaugural innovative drug catalog for private insurance. This list, launched on October...
Eli Lilly has announced a reduction in the price of its obesity treatment, Zepbound, to enhance affordability for U.S. patients. Starting immediately, patients with a prescription...
Eli Lilly has announced a significant reduction in the prices of its obesity treatment, Zepbound, aiming to increase accessibility for U.S. patients. As of March 2024,...
Mangoceuticals (MGRX) has announced a strategic partnership with pharmaceutical leaders Eli Lilly (LLY) and Novo Nordisk (NVO) to facilitate direct sales of their GLP-1 weight loss...
This week saw significant movements in the business landscape, highlighted by the acquisition of Plymouth Industrial REIT (NYSE: PLYM). Entities associated with Makarora Management and funds...
This week saw significant business activity as entities linked to Makarora Management and Ares Alternative Credit entered into an agreement to acquire all outstanding shares of...
